Trial intelligence / Profile preview

Zolmitriptan Nasal Spray in Adolescent Migraine

NCT00617695Phase 3Completed

Sponsor
Impax Laboratories
Start
Sep 2003
Modality
Small Molecules
01

Overview

A Phase 3 trial of zolmitriptan in migraine, sponsored by Impax Laboratories. Started Sep 2003; status: completed.

02

Drugs

zolmitriptan
03

Conditions

migraine

Beyond the preview

Go deeper on NCT00617695.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00617695.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call